Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1965 3
1966 1
1967 2
1968 1
1969 2
1979 1
1988 1
1989 1
1990 1
1993 1
1994 1
1996 3
1997 2
1998 2
1999 6
2000 3
2001 5
2002 7
2003 10
2004 5
2005 11
2006 17
2007 19
2008 20
2009 23
2010 24
2011 26
2012 12
2013 14
2014 28
2015 33
2016 37
2017 39
2018 45
2019 62
2020 51
2021 51
2022 61
2023 57
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

621 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Gomez-Jemes
Page 1
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. Jain A, et al. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34822189 Clinical Trial.
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We evaluated the role of intravenous LOLA in patients of cirrhosis with OHE grade III-IV. ...LOLA was given as continuous intrave …
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We …
Lola.
Sedehi N. Sedehi N. Acad Psychiatry. 2022 Aug;46(4):534. doi: 10.1007/s40596-022-01656-7. Epub 2022 Jun 3. Acad Psychiatry. 2022. PMID: 35661337 No abstract available.
Management of Portal Hypertension.
Kulkarni AV, Rabiee A, Mohanty A. Kulkarni AV, et al. J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1184-1199. doi: 10.1016/j.jceh.2022.03.002. Epub 2022 Mar 21. J Clin Exp Hepatol. 2022. PMID: 35814519 Free PMC article. Review.
Encephalopathy in Cirrhosis: Prevention and Management.
Sahney A, Wadhawan M. Sahney A, et al. J Clin Exp Hepatol. 2022 May-Jun;12(3):927-936. doi: 10.1016/j.jceh.2021.12.007. Epub 2021 Dec 22. J Clin Exp Hepatol. 2022. PMID: 35677508 Free PMC article. Review.
Physical Rehabilitation for Small Animals.
Gamble LJ. Gamble LJ. Vet Clin North Am Small Anim Pract. 2022 Jul;52(4):997-1019. doi: 10.1016/j.cvsm.2022.03.005. Epub 2022 May 11. Vet Clin North Am Small Anim Pract. 2022. PMID: 35562217 Review.
Nephrology from a gender perspective.
Arenas Jiménez MD, Martin-Gómez MA, Carrero JJ, Ruiz Cantero MT. Arenas Jiménez MD, et al. Nefrologia (Engl Ed). 2018 Sep-Oct;38(5):463-465. doi: 10.1016/j.nefro.2018.04.001. Epub 2018 May 24. Nefrologia (Engl Ed). 2018. PMID: 29803293 Free article. English, Spanish. No abstract available.
L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
Butterworth RF, McPhail MJW. Butterworth RF, et al. Drugs. 2019 Feb;79(Suppl 1):31-37. doi: 10.1007/s40265-018-1024-1. Drugs. 2019. PMID: 30706425 Free PMC article. Review.
This manuscript represents an appraisal of the evidence in support of L-ornithine-L-aspartate (LOLA) for the management and treatment of hepatic encephalopathy (HE) in cirrhosis. ...These findings provide support for the use of LOLA in the treatment of HE and future …
This manuscript represents an appraisal of the evidence in support of L-ornithine-L-aspartate (LOLA) for the management and treatment …
Traumatic lung hernia.
Freire Aragón MD, Palacios García I, Rivera Fernández V. Freire Aragón MD, et al. Med Intensiva (Engl Ed). 2018 May;42(4):e5. doi: 10.1016/j.medin.2016.09.001. Epub 2016 Oct 21. Med Intensiva (Engl Ed). 2018. PMID: 27776935 English, Spanish. No abstract available.
A Paradigm Shift for Resectable Non-Small Cell Lung Cancer.
Isla D, Majem M. Isla D, et al. Arch Bronconeumol. 2022 Dec;58(12):792-793. doi: 10.1016/j.arbres.2022.04.004. Epub 2022 May 1. Arch Bronconeumol. 2022. PMID: 35595655 English, Spanish. No abstract available.
621 results